TY - JOUR
T1 - Further evidence that lucigenin-derived chemiluminescence monitors mitochondrial superoxide generation in rat alveolar macrophages
AU - Rembish, Stephen J.
AU - Trush, Michael A.
N1 - Funding Information:
CL from lucigenin, this source being the mitochondria.8 This concept was supported by the ability of rat liver submitochondrial particles supplemented with
PY - 1994/8
Y1 - 1994/8
N2 - Lucigenin is well recognized for its ability to react with superoxide, yielding a product that emits chemiluminescence. Accordingly, lucigenin-derived chemiluminescence (LDCL) has been widely used to assess the generation of superoxide by the NADPH oxidase of leukocytes. Previously, we suggested that lucigenin could interact with mitochondrial-derived superoxide in alveolar macrophages. The purpose of this study was to further demonstrate that LDCL is in fact a probe of mitochondrial superoxide generation. Using fluorescence microscopy, we have observed that lucigenin accumulates at the mitochondria of alveolar macrophages and exhibits a localization similar to that of rhodamine 123, a fluorescent indicator of mitochondrial membrane potential. We have also compared the effects of a spectrum of agents known to modulate mitochondrial respiration on both LDCL and cellular oxygen consumption. The agents examined included a Complex I inhibitor, rotenone; a Complex III inhibitor, antimycin a; and a Complex IV inhibitor, KCN. While these compound all inhibited oxygen consumption, only those that exert an effect prior to (rotenone) or at (antimycin a) the point of mitochondrial superoxide formation inhibited LDCL. KCN exhibits effects that are concetration dependent. At low concentrations (1-100 μM), a slight enhancement of LDCL is observed, while at higher concentrations (1-10 mM) both LDCL and oxygen consumption are inhibited. The ATP synthase inhibitor, oligomycin, was also observed to correspondingly inhibit oxygen consumption and LDCL. These inhibitor studies, taken together with the observation that lucigenin localizes to the mitochondria of alveolar macrophages, provides strong evidence that LDCL can be used to qualitatively asses the modulation of mitochondrial superoxide generation in mononuclear cells.
AB - Lucigenin is well recognized for its ability to react with superoxide, yielding a product that emits chemiluminescence. Accordingly, lucigenin-derived chemiluminescence (LDCL) has been widely used to assess the generation of superoxide by the NADPH oxidase of leukocytes. Previously, we suggested that lucigenin could interact with mitochondrial-derived superoxide in alveolar macrophages. The purpose of this study was to further demonstrate that LDCL is in fact a probe of mitochondrial superoxide generation. Using fluorescence microscopy, we have observed that lucigenin accumulates at the mitochondria of alveolar macrophages and exhibits a localization similar to that of rhodamine 123, a fluorescent indicator of mitochondrial membrane potential. We have also compared the effects of a spectrum of agents known to modulate mitochondrial respiration on both LDCL and cellular oxygen consumption. The agents examined included a Complex I inhibitor, rotenone; a Complex III inhibitor, antimycin a; and a Complex IV inhibitor, KCN. While these compound all inhibited oxygen consumption, only those that exert an effect prior to (rotenone) or at (antimycin a) the point of mitochondrial superoxide formation inhibited LDCL. KCN exhibits effects that are concetration dependent. At low concentrations (1-100 μM), a slight enhancement of LDCL is observed, while at higher concentrations (1-10 mM) both LDCL and oxygen consumption are inhibited. The ATP synthase inhibitor, oligomycin, was also observed to correspondingly inhibit oxygen consumption and LDCL. These inhibitor studies, taken together with the observation that lucigenin localizes to the mitochondria of alveolar macrophages, provides strong evidence that LDCL can be used to qualitatively asses the modulation of mitochondrial superoxide generation in mononuclear cells.
KW - Alveolar macrophages
KW - Chemiluminescence
KW - Electron transport chain
KW - Free radicals
KW - Lucigenin
KW - Mitochondria
KW - Oxygen consumption
KW - Superoxide anion
UR - http://www.scopus.com/inward/record.url?scp=0028305910&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0028305910&partnerID=8YFLogxK
U2 - 10.1016/0891-5849(94)90109-0
DO - 10.1016/0891-5849(94)90109-0
M3 - Article
C2 - 7959172
AN - SCOPUS:0028305910
SN - 0891-5849
VL - 17
SP - 117
EP - 126
JO - Free Radical Biology and Medicine
JF - Free Radical Biology and Medicine
IS - 2
ER -